Literature DB >> 17288909

[Guidelines for the diagnosis and treatment of patients with bacteriemia. Guidelines of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].

José Miguel Cisneros-Herreros1, Javier Cobo-Reinoso, Miquel Pujol-Rojo, Jesús Rodríguez-Baño, Miguel Salavert-Lletí.   

Abstract

Bacteremia is a complex clinical syndrome in constant transformation that is an important, growing cause of morbidity and mortality. Even though there is a great deal of specific information about bacteremia, few comprehensive reviews integrate this information with a practical AIM. The main objective of these Guidelines, which target hospital physicians, is to improve the clinical care provided to patients with bacteremia by integrating blood culture results with clinical data, and optimizing the use of diagnostic procedures and antimicrobial testing. The document is structured into sections that cover the epidemiology and etiology of bacteremia, stratified according to the various patient populations, and the diagnostic work-up, therapy, and follow-up of patients with bacteremia. Diagnostic and therapeutic decisions are presented as recommendations based on the grade of available scientific evidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17288909     DOI: 10.1016/s0213-005x(07)74242-8

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  11 in total

1.  A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS.

Authors:  P M Juiz; M Almela; C Melción; I Campo; C Esteban; C Pitart; F Marco; J Vila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-26       Impact factor: 3.267

2.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

3.  Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.

Authors:  Luis García de Guadiana-Romualdo; Ignacio Español-Morales; Pablo Cerezuela-Fuentes; Luciano Consuegra-Sánchez; Ana Hernando-Holgado; Patricia Esteban-Torrella; Enrique Jiménez-Santos; Monserrat Viqueira-González; África de Béjar-Almira; María Dolores Albaladejo-Otón
Journal:  Support Care Cancer       Date:  2015-01-07       Impact factor: 3.603

4.  A bacteraemia risk prediction model: development and validation in an emergency medicine population.

Authors:  Agustín Julián-Jiménez; Juan González Del Castillo; Eric Jorge García-Lamberechts; Itziar Huarte Sanz; Carmen Navarro Bustos; Rafael Rubio Díaz; Josep María Guardiola Tey; Ferrán Llopis-Roca; Pascual Piñera Salmerón; Mikel de Martín-Ortiz de Zarate; Jesús Álvarez-Manzanares; Julio Javier Gamazo-Del Rio; Marta Álvarez Alonso; Begoña Mora Ordoñez; Oscar Álvarez López; María Del Mar Ortega Romero; María Del Mar Sousa Reviriego; Ramón Perales Pardo; Henrique Villena García Del Real; María José Marchena González; José María Ferreras Amez; Félix González Martínez; Francisco Javier Martín-Sánchez; Pedro Beneyto Martín; Francisco Javier Candel González; Antonio Jesús Díaz-Honrubia
Journal:  Infection       Date:  2021-09-06       Impact factor: 3.553

5.  Adherence to recommendations by infectious disease consultants and its influence on outcomes of intravenous antibiotic-treated hospitalized patients.

Authors:  María-Carmen Fariñas; Gabriela Saravia; Jorge Calvo-Montes; Natividad Benito; Juan-José Martínez-Garde; Concepción Fariñas-Alvarez; Lorenzo Aguilar; Ramón Agüero; José-Antonio Amado; Luis Martínez-Martínez; Manuel Gómez-Fleitas
Journal:  BMC Infect Dis       Date:  2012-11-09       Impact factor: 3.090

6.  Community-Onset Bloodstream and Other Infections, Caused by Carbapenemase-Producing Enterobacteriaceae: Epidemiological, Microbiological, and Clinical Features.

Authors:  José Ramón Paño-Pardo; Beatriz López Quintana; Fernando Lázaro Perona; Guillermo Ruiz Carrascoso; María Pilar Romero-Gómez; Belén Loeches Yagüe; Beatriz Díaz-Pollán; Ana Martínez-Virto; Jesús Mingorance; Julio García Rodríguez; José Ramón Arribas; Rosa Gómez-Gil
Journal:  Open Forum Infect Dis       Date:  2016-08-01       Impact factor: 3.835

7.  Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial.

Authors:  Luis Eduardo López-Cortés; Clara Rosso-Fernández; María Núñez-Núñez; Lucía Lavín-Alconero; José Bravo-Ferrer; Ángel Barriga; Mercedes Delgado; Carmen Lupión; Pilar Retamar; Jesús Rodríguez-Baño
Journal:  BMJ Open       Date:  2017-06-09       Impact factor: 2.692

8.  Results of an early intervention programme for patients with bacteraemia: analysis of prognostic factors and mortality.

Authors:  A Del Arco; J Olalla; J de la Torre; A Blázquez; N Montiel-Quezel; J L Prada; F Rivas; J García-Alegría; F Fernández-Sánchez
Journal:  BMC Infect Dis       Date:  2017-05-22       Impact factor: 3.090

9.  Catheter-related bloodstream infections with coagulase-negative staphylococci: are antibiotics necessary if the catheter is removed?

Authors:  Ursula Patricia Hebeisen; Andrew Atkinson; Jonas Marschall; Niccolò Buetti
Journal:  Antimicrob Resist Infect Control       Date:  2019-01-29       Impact factor: 4.887

10.  Real-World Use of Generic Meropenem: Results of an Observational Study.

Authors:  Santiago Garnica-Velandia; Luz Adriana Aristizábal-Ruiz; Carlos Arturo Alvarez-Moreno
Journal:  Antibiotics (Basel)       Date:  2021-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.